Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
Pharmacokinetics |
What the body does to/with the drug as a function of time.
Guides dosing |
|
Minimum effective concentration
|
lowest plasma protein concentration required to cause measurable response. Time called onset of action
|
|
Duration of action
|
time period when plasma concentration is above MEC
|
|
Therapeutic index/range
|
ratio between toxic dose and effective dose
|
|
Biological/elimination half-life
|
time it takes, after absorption for 50% of drug to be eliminated
it takes 4 - 5 half lives to eliminate around 98% Helps determine duration of action |
|
Multiple dosing
|
dose approximately every half-life in order to maintain steady state-blood levels
|
|
Loading doses
|
giving higher than maintenance doses in order to rapidly reach steady-state blood levels
|
|
Factors affecting pharmacokinetics (5)
|
dose, frequency, condition of body systems, drug form, route
|
|
Drug-receptor interaction theory
|
drug chemicals interact with receptors in luck and key fashion. Only certain keys fit certain locks. Specificity
|
|
Rate interaction theory
|
rate of binding determines the type and intensity of response
greater affinity or concentration of drug will increase rate and thus response |
|
Agonist
|
chemical that combines with a receptor to produce a response
|
|
Antagonist
|
combines with receptor and inhibits action of agonist, the antagonist alone has no action
|
|
Competitive antagonist
|
binds with receptor at same site as agonist, has higher affinity for receptor than agonist has
can be overcome by higher concentration of agonist |
|
Non-competitive antagonist
|
binds with receptor at site other than active site for agonist, creates change in receptor that prevents agonist binding
Cannot be overcome by higher agonist concentration |
|
Potentiation
|
effect of one drug increased by the second
1 + 1 = 2 increased absorption, concentration at site slower metabolism, excretion |
|
Synergism
|
combined effect greater than each drug given alone
1 + 1 = 3 Ex) antibiotics for UTIs |
|
Side effect (secondary effect)
|
ANY effect other than primary therapeutic effect
|
|
Adverse reaction
|
noxious, unwanted, unintended
severe = toxicity considered reportable to FDA or monitoring agencies |
|
Hypersensitivity
|
ANY excessive reaction
|
|
Idiosyncratic response
|
uncommon response, may be due to genetic predisposition
|
|
Allergy
|
histamine-mediated response, requires sensitization, severity varies
|
|
Anaphylaxis
|
Massive histamine release, abrupt onset
|
|
Integumentary reactions
|
hives/uritcaria, drug eruptions/rash, contact dermatitis, eczema, photosensitivity
angioedema - histamine mediated reaction in skin, mucous membranes, and/or internal organs |
|
Serum sickness
|
Type III hypersensitivity reaction, more delayed, rare
skin rashes, edema, joint pain (arthralgia), anaphylaxis may follow |
|
Erythema multiformae
|
delayed hypersensitivity reaction, complement system, "bulls-eye" lesions that may necrose
|
|
Stevens-Johnson syndrome
|
more sever fore of EM, "bulls-eye" lesions but involve mucous membranes too, joint pain, lesions may erode/necrose, painful, fever, malaise
|
|
Toxic epidermal necrolysis
|
more sever form of EM, "bully-eye" lesions coalesce, skin sloughs off
|
|
Most common GI disturbance
|
Nausea/vomiting
|
|
Pseudomembranous colitis
|
overgrowth of Clostridium dificile
diarrhea is worsening, mucus containing, bloody, distinct smell |
|
May lead to GI bleeds:
|
NSAIDs, corticosteroids
|
|
Nursing actions for possible nephrotoxicity
|
Monitor BUN, creatinine, urine output, good hydration, pre-hydrate, use diuretic to move drug through faster, monitor therapeutic blood levels
Ex) antibiotics, antineoplastics (chemo) |
|
Toxicity to eight cranial nerve is:
|
ototoxicity
|
|
Paradoxical reactions
|
opposite of expected therapeutic result
|
|
Extrapyramidal reactions (Parkinsonian symptoms)
|
extrapyramidal tracts are motor tracks in nervous system
tremor, gait disturbances, rigidity |
|
Myocardial toxicity
|
causes cardiomyopathy, direct damage to myocardial tissue
|
|
Cardiac vasoconstrictive agents
|
Cocaine, meth, illicit drugs
|
|
Blood dyscrasias
|
dysfunction of flood forming organs, big broad vague
"bone marrow suppression/depression" |
|
Aplastic anemia
|
lack of production of all blood cells
|
|
Hemolytic anemia
|
direct RBC damage/destruction, can cause renal failure if heme clog glomerulus
|
|
Neutropenic precautions
|
neutropenic = low neutrophils/WBCs
isolation, prevent infection |
|
Toxic hepatitis
|
NOT infectious hepatitis, looks like viral form though
Acetominophen, antilipemic drugs |
|
Teratogenicity
|
ability to harm fetus/cause birth defects
drugs organized in categories A, B, C, D, X |
|
Factors affecting adverse drug reactions (6)
|
age, gender, genetic predisposition, history (of allergies), current disease state, pharmacodynamic/kinetic factors
|